ArticleVirulence2023

Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India.

Naveen Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.